ArticleJournal of neuroinflammation2021

The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's disease.

Neus Rabaneda-Lombarte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.